News
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Spirent “Send Us Your Device” Service Opens Up New Routes For Wi-Fi Equipment Testing
Spirent Communications plc (LSE:SPT), the leading provider of test and assurance solutions for next-generation devices and networks, today announced the launch of a new “Send Us Your Device” Test
Director/PDMR Shareholding
Correction: Director/PDMR Shareholding
Director/PDMR Shareholding
Spirent Vantage Signals a New Era of 5G Network-Aware Service Assurance
Spirent Communications plc (LSE: SPT), the leading provider of test and assurance solutions for next-generation devices and networks, today announced the introduction of Spirent Vantage, an
Spirent Showcases Industry-First Ethernet Validation - Crucial to Maintaining Explosive Growth of the Cloud
Spirent Communications plc (LSE:SPT), the leading provider of test and assurance solutions for next-generation devices and networks, today announced the availability of its latest 400G and 800G
Operator 5G Engagements Increase by More Than 50%, Driven by Standalone Core, Network Cloudification and Operational Agility
Spirent Communications plc (LSE:SPT), the leading provider of test and assurance solutions for next-generation devices and networks, today released its third annual 5G outlook report, based on
Form 8.3 - Maitland Institutional Services Limited: Re Tungsten Corp plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
ADC Therapeutics gibt freiwillige Unterbrechung der Aufnahme in die klinische Phase-II-Studie LOTIS-9 zu ZYNLONTA® (Loncastuximab-Tesirin-Lpyl) und Rituximab bei nicht fitten oder gebrechlichen, zuvor unbehandelten DLBCL-Patienten bekannt
LAUSANNE, Schweiz, July 12, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) hat heute eine freiwillige Unterbrechung der Aufnahme neuer Patienten in die klinische Phase-II-Studie LOTIS-9